Font Size: a A A

Research On Indicator System Of Top Pharmaceutical Companies'S&T Competitiveness

Posted on:2012-06-08Degree:MasterType:Thesis
Country:ChinaCandidate:L F MaFull Text:PDF
GTID:2189330335482051Subject:Information Science
Abstract/Summary:PDF Full Text Request
S&T competitiveness is one of the abilities top pharmaceutical companies must have to discover new drugs and create promotional marketing. It also meets companies' tech-intensive feature and competitive environment requirement. This thesis used indicator system, which is a commonly used method, to analyze top pharmaceutical companies'S&T activities and resources, so as to reflect S&T competitiveness.This thesis applied literature investigation method to summarize five important influence factors, based on the review of general enterprise indicators and top pharmaceutical companies'characteristics. Following the indicator selection principle and design idea, it turned out an indicator system framework. According to the results of two round expert questionnaire surveys and one round Analytic Hierarchy Process (AHP) survey, a final indicator system was formed, including four primary indicators and fourteen ranked secondary indicators. Four primary indicators are S&T input, output, management and support aspects. Fourteen ranked secondary indicators are sci-tech personnel (team), R&D expense, new drugs, patents, innovation strategies, etc. After preliminary test and intensive study, it suggested the indicator system was repeatable and operable, and could reflect the S&T competitiveness of top pharmaceutical enterprises.There are four key viewpoints from indicator system evaluation:R&D team is the motivation of competitiveness improvement, both quantity advantage and management are important to big pharma firms; research conditions, including instrument equipments, R&D centers and information systems, are effective ways to enhance competitive efficiency of R&D expense; S&T innovation tactics obtain a differentiate competitive advantage from drug discovery plans, patent strategies and market leadership; strategic technology reserve, related to the performance of competitive technical intelligence, innovation strategies and brand/pipeline products'technology transformation, ensures to stay ahead of present or potential competition.
Keywords/Search Tags:top pharmaceutical company, S&T innovation, competitiveness, indicator
PDF Full Text Request
Related items